Activity Overview
This educational activity is an archive of the live conference held on March 13-14, 2026.
Target Audience
This educational activity is directed toward medical, surgical,
and radiation oncologists involved in the treatment of patients with GU
malignancies. Urologists, fellows, nurse practitioners, nurses, physician
assistants, pharmacists, researchers, nuclear medicine physicians, and other
health care professionals interested in the treatment of GU malignancies may
also participate.
Learning Objectives
- Interpret advanced diagnostic and molecular testing strategies—including ctDNA and genomic profiling—for risk stratification and disease monitoring in GU malignancies
- Apply molecular and genomic test results to guide treatment selection and personalize care in patients with GU cancers
- Integrate emerging therapies with multidisciplinary strategies to optimize treatment sequencing and coordination across specialties

Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and Urology
Director, Genitourinary Oncology Research Program
Co-Director, Signal Transduction Program
Yale Cancer Center
Yale School of Medicine
New Haven, CT

E. David Crawford, MD
Professor of Urology
Jack A. Vickers Director of Prostate Research
University of California, San Diego
Koman Family Outpatient Pavilion
La Jolla, CA

Michael S. Leapman, MD, MHS
Associate Professor of Urology
Assistant Professor, Chronic Disease Epidemiology
Yale School of Medicine
Clinical Program Leader, Prostate & Urologic Cancers Program
Yale Cancer Center
New Haven, CT

Lawrence H. Schwartz, MD
Chair, Department of Radiology
Hedvig Hricak Chair in Radiology
Memorial Sloan Kettering Cancer Center
New York, NY

Rahul Aggarwal, MD
Professor of Medicine
Thomas Perkins Distinguished Professor of Cancer Research
Program Director, Genitourinary Medical Oncology
Associate Director for Clinical Research
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA

Maha Hussain, MD, FACP, FASCO
Genevieve Teuton Professor of Medicine
Division of Hematology/Oncology
Deputy Director
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of
Medicine
Chicago, IL

Tanya Barauskas Dorff, MD
Division Chief, Genitourinary Cancers
Vice Chair for Clinical Affairs
Professor of Medicine
Department of Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, CA

Isaac Y. Kim, MD, PhD, MBA
Professor of Urology
Chair, Urology
Yale School of Medicine
Co-Leader, Cancer Signaling Networks
Yale Cancer Center
New Haven, CT

Anthony V. D’Amico, MD, PhD
Professor of Radiation Oncology
Harvard Medical School
Chief of Genitourinary Radiation Oncology
Brigham and Women’s Hospital
Dana-Farber Cancer Institute
Boston, MA
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here